Search research articles
Contact Us
Filters
Showing results (1-10 of 21) with videos related to
Page
of 3
Sort By:
Drug Safety
|
February 15, 2000
Managing the adverse effects of interferon-beta therapy in multiple sclerosis
A Bayas, P Rieckmann
Fortschritte Der Neurologie-Psychiatrie
|
February 13, 2003
[Diagnostic principles in myopathies]
A Bayas, R Gold
Multiple Sclerosis and Related Disorders
|
September 17, 2022
Self-assessment of people with relapsing-remitting and progressive multiple sclerosis towards burden of disease, progression, and treatment utilization-Results of a large-scale cross-sectional online survey (MS Perspectives)
A Bayas, K Schuh, M Christ
Acta Neurologica Scandinavica
|
September 28, 2011
Accidental natalizumab administration to the third trimester of pregnancy in an adolescent patient with multiple sclerosis
A Bayas, J Penzien, K Hellwig
Acta Neurologica Scandinavica
|
June 8, 2012
Accidental natalizumab administration in pregnancy in multiple sclerosis
A Bayas, J Penzien, K Hellwig
Der Nervenarzt
|
August 5, 2005
[Autoimmune neuropathies--current aspects of immunopathologic diagnostics and therapy]
R Gold, A Bayas, K V Toyka
Acta Neuropathologica
|
January 1, 1994
Interphase cytogenetics of glioblastoma and gliosarcoma
W Paulus, A Bayas, G Ott, et al.
Journal of Neurology
|
February 1, 2000
Meningioma associated with McCune-Albright syndrome
A Bayas, M Naumann, S Wever, et al.
Neurological Research and Practice
|
August 7, 2021
Controversy on the treatment of multiple sclerosis and related disorders: positional statement of the expert panel in charge of the 2021 DGN Guideline on diagnosis and treatment of multiple sclerosis, neuromyelitis optica spectrum diseases and MOG-IgG-associated disorders
A Bayas, A Berthele, B Hemmer, et al.
Der Nervenarzt
|
April 1, 2022
[Spontaneous intracranial hypotension with brain sagging and reversible frontotemporal dementia : Case report and review of the literature]
C Hagemann, M Christ, C Maurer, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 21) with videos related to
Sort By:
Page
of 3
Drug Safety
|
February 15, 2000
Managing the adverse effects of interferon-beta therapy in multiple sclerosis
A Bayas, P Rieckmann
Fortschritte Der Neurologie-Psychiatrie
|
February 13, 2003
[Diagnostic principles in myopathies]
A Bayas, R Gold
Multiple Sclerosis and Related Disorders
|
September 17, 2022
Self-assessment of people with relapsing-remitting and progressive multiple sclerosis towards burden of disease, progression, and treatment utilization-Results of a large-scale cross-sectional online survey (MS Perspectives)
A Bayas, K Schuh, M Christ
Acta Neurologica Scandinavica
|
September 28, 2011
Accidental natalizumab administration to the third trimester of pregnancy in an adolescent patient with multiple sclerosis
A Bayas, J Penzien, K Hellwig
Acta Neurologica Scandinavica
|
June 8, 2012
Accidental natalizumab administration in pregnancy in multiple sclerosis
A Bayas, J Penzien, K Hellwig
Der Nervenarzt
|
August 5, 2005
[Autoimmune neuropathies--current aspects of immunopathologic diagnostics and therapy]
R Gold, A Bayas, K V Toyka
Acta Neuropathologica
|
January 1, 1994
Interphase cytogenetics of glioblastoma and gliosarcoma
W Paulus, A Bayas, G Ott, et al.
Journal of Neurology
|
February 1, 2000
Meningioma associated with McCune-Albright syndrome
A Bayas, M Naumann, S Wever, et al.
Neurological Research and Practice
|
August 7, 2021
Controversy on the treatment of multiple sclerosis and related disorders: positional statement of the expert panel in charge of the 2021 DGN Guideline on diagnosis and treatment of multiple sclerosis, neuromyelitis optica spectrum diseases and MOG-IgG-associated disorders
A Bayas, A Berthele, B Hemmer, et al.
Der Nervenarzt
|
April 1, 2022
[Spontaneous intracranial hypotension with brain sagging and reversible frontotemporal dementia : Case report and review of the literature]
C Hagemann, M Christ, C Maurer, et al.
Page
of 3